NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Tuesday, October 30th. Stockholders of record on Friday, December 14th will be given a dividend of $0.335 per share on Wednesday, January 2nd. This represents a $1.34 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date is Thursday, December 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) issued its earnings results on Wednesday, February, 20th. The specialty chemicals company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.07. The specialty chemicals company had revenue of $921.70 million for the quarter, compared to analyst estimates of $894.45 million. Albemarle had a return on equity of 15.82% and a net margin of 20.55%. The company's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.34 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Albemarle.

Albemarle updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided earnings per share (EPS) guidance of $6.10-6.50 for the period, compared to the Thomson Reuters consensus estimate of $6.14. The company issued revenue guidance of $3.65-3.85 billion, compared to the consensus revenue estimate of $3.64 billion.Albemarle also updated its FY 2019 guidance to $6.10-6.50 EPS.

17 brokerages have issued 1-year price objectives for Albemarle's shares. Their forecasts range from $59.00 to $150.00. On average, they anticipate Albemarle's share price to reach $107.4131 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price. View Analyst Price Targets for Albemarle.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

News headlines about ALB stock have trended negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave news coverage about the specialty chemicals company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), Rogers (ROG), PolyOne (POL), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), Cereplast (CERPQ), A Schulman (SHLM) and ForceField Energy (FNRG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), NVIDIA (NVDA), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), General Electric (GE), Intel (INTC), Netflix (NFLX) and AutoCanada (ACQ).

Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.01%), Jennison Associates LLC (6.55%), Bank of New York Mellon Corp (3.02%), Baillie Gifford & Co. (2.48%), Bank of America Corp DE (1.78%) and Iridian Asset Management LLC CT (1.63%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Jennison Associates LLC, Carmignac Gestion, Mirae Asset Global Investments Co. Ltd., Iridian Asset Management LLC CT, QCI Asset Management Inc. NY, Anchor Bolt Capital LP and United Services Automobile Association. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was bought by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., State of Tennessee Treasury Department, Principal Financial Group Inc., Robecosam AG, CIBC Private Wealth Group LLC, Dimensional Fund Advisors LP, Handelsbanken Fonder AB and State of New Jersey Common Pension Fund D. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $89.18.

Albemarle has a market capitalization of $9.47 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]